Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 1/2012

01-02-2012 | Erratum

Erratum to: Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD

Authors: Maher R. Khdour, Ashley M. Agus, Joseph C. Kidney, Bronagh M. Smyth, James C. McElnay, Grainne E. Crealey

Published in: International Journal of Clinical Pharmacy | Issue 1/2012

Login to get access

Excerpt

Unfortunately, one of the author’s names has been misspelled in the original publication of the article. The corrected spelling should read James C. McElnay. …
Metadata
Title
Erratum to: Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD
Authors
Maher R. Khdour
Ashley M. Agus
Joseph C. Kidney
Bronagh M. Smyth
James C. McElnay
Grainne E. Crealey
Publication date
01-02-2012
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 1/2012
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9598-7

Other articles of this Issue 1/2012

International Journal of Clinical Pharmacy 1/2012 Go to the issue

Short Research Report

Activated protein C in patients with septic shock: a consecutive case series

Research Article

Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study

Research Article

Perceived value of ward-based pharmacists from the perspective of physicians and nurses

Research Article

Impact of pharmaceutical care on health outcomes in patients with COPD

Case Report

Vancomycin-induced red man syndrome in pediatric oncology: still an issue?

Research Article

Off-label prescriptions for adult neurological patients: a pilot survey in China
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits